Dolutegravir/Rilpivirine Combination Drug
Dolutegravir/Rilpivirine Combination Drug market is segmented by region (country), players, by Ty ... Read More
1 Study Coverage 1.1 Rilpivirine Product Introduction 1.2 Global Rilpivirine Outlook 2017 VS 2022 VS 2028 1.2.1 Global Rilpivirine Sales in US$ Million for the Year 2017-2028 1.2.2 Global Rilpivirine Sales in Volume for the Year 2017-2028 1.3 United States Rilpivirine Outlook 2017 VS 2022 VS 2028 1.3.1 United States Rilpivirine Sales in US$ Million for the Year 2017-2028 1.3.2 United States Rilpivirine Sales in Volume for the Year 2017-2028 1.4 Rilpivirine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Rilpivirine in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Rilpivirine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Rilpivirine Market Dynamics 1.5.1 Rilpivirine Industry Trends 1.5.2 Rilpivirine Market Drivers 1.5.3 Rilpivirine Market Challenges 1.5.4 Rilpivirine Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Rilpivirine Market Segment by Type 2.1.1 Self-production API 2.1.2 Outsourcing of API 2.2 Global Rilpivirine Market Size by Type 2.2.1 Global Rilpivirine Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Rilpivirine Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Rilpivirine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Rilpivirine Market Size by Type 2.3.1 United States Rilpivirine Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Rilpivirine Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Rilpivirine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Rilpivirine Market Segment by Application 3.1.1 Hospital 3.1.2 Clinic 3.1.3 Drug Center 3.1.4 Other 3.2 Global Rilpivirine Market Size by Application 3.2.1 Global Rilpivirine Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Rilpivirine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Rilpivirine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Rilpivirine Market Size by Application 3.3.1 United States Rilpivirine Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Rilpivirine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Rilpivirine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Rilpivirine Competitor Landscape by Company 4.1 Global Rilpivirine Market Size by Company 4.1.1 Top Global Rilpivirine Manufacturers Ranked by Revenue (2021) 4.1.2 Global Rilpivirine Revenue by Manufacturer (2017-2022) 4.1.3 Global Rilpivirine Sales by Manufacturer (2017-2022) 4.1.4 Global Rilpivirine Price by Manufacturer (2017-2022) 4.2 Global Rilpivirine Concentration Ratio (CR) 4.2.1 Rilpivirine Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rilpivirine in 2021 4.2.3 Global Rilpivirine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Rilpivirine Manufacturing Base Distribution, Product Type 4.3.1 Global Rilpivirine Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Rilpivirine Product Type 4.3.3 Date of International Manufacturers Enter into Rilpivirine Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Rilpivirine Market Size by Company 4.5.1 Top Rilpivirine Players in United States, Ranked by Revenue (2021) 4.5.2 United States Rilpivirine Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Rilpivirine Sales by Players (2020, 2021 & 2022) 5 Global Rilpivirine Market Size by Region 5.1 Global Rilpivirine Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Rilpivirine Market Size in Volume by Region (2017-2028) 5.2.1 Global Rilpivirine Sales in Volume by Region: 2017-2022 5.2.2 Global Rilpivirine Sales in Volume Forecast by Region (2023-2028) 5.3 Global Rilpivirine Market Size in Value by Region (2017-2028) 5.3.1 Global Rilpivirine Sales in Value by Region: 2017-2022 5.3.2 Global Rilpivirine Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Rilpivirine Market Size YoY Growth 2017-2028 6.1.2 North America Rilpivirine Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Rilpivirine Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Rilpivirine Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Rilpivirine Market Size YoY Growth 2017-2028 6.3.2 Europe Rilpivirine Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Rilpivirine Market Size YoY Growth 2017-2028 6.4.2 Latin America Rilpivirine Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Rilpivirine Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Rilpivirine Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Janssen Cilag International 7.1.1 Janssen Cilag International Corporation Information 7.1.2 Janssen Cilag International Description and Business Overview 7.1.3 Janssen Cilag International Rilpivirine Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Janssen Cilag International Rilpivirine Products Offered 7.1.5 Janssen Cilag International Recent Development 7.2 Gilead Sciences 7.2.1 Gilead Sciences Corporation Information 7.2.2 Gilead Sciences Description and Business Overview 7.2.3 Gilead Sciences Rilpivirine Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Gilead Sciences Rilpivirine Products Offered 7.2.5 Gilead Sciences Recent Development 7.3 ViiV Healthcare 7.3.1 ViiV Healthcare Corporation Information 7.3.2 ViiV Healthcare Description and Business Overview 7.3.3 ViiV Healthcare Rilpivirine Sales, Revenue and Gross Margin (2017-2022) 7.3.4 ViiV Healthcare Rilpivirine Products Offered 7.3.5 ViiV Healthcare Recent Development 7.4 Strides Pharma Science Limited 7.4.1 Strides Pharma Science Limited Corporation Information 7.4.2 Strides Pharma Science Limited Description and Business Overview 7.4.3 Strides Pharma Science Limited Rilpivirine Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Strides Pharma Science Limited Rilpivirine Products Offered 7.4.5 Strides Pharma Science Limited Recent Development 7.5 Pharmacare Limited 7.5.1 Pharmacare Limited Corporation Information 7.5.2 Pharmacare Limited Description and Business Overview 7.5.3 Pharmacare Limited Rilpivirine Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Pharmacare Limited Rilpivirine Products Offered 7.5.5 Pharmacare Limited Recent Development 7.6 Aspen 7.6.1 Aspen Corporation Information 7.6.2 Aspen Description and Business Overview 7.6.3 Aspen Rilpivirine Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Aspen Rilpivirine Products Offered 7.6.5 Aspen Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Rilpivirine Industry Chain Analysis 8.2 Rilpivirine Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Rilpivirine Distributors 8.3 Rilpivirine Production Mode & Process 8.4 Rilpivirine Sales and Marketing 8.4.1 Rilpivirine Sales Channels 8.4.2 Rilpivirine Distributors 8.5 Rilpivirine Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. Rilpivirine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Rilpivirine Market Trends Table 3. Rilpivirine Market Drivers Table 4. Rilpivirine Market Challenges Table 5. Rilpivirine Market Restraints Table 6. Global Rilpivirine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Rilpivirine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Rilpivirine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Rilpivirine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Rilpivirine Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Rilpivirine Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Rilpivirine Revenue Share by Manufacturer, 2017-2022 Table 13. Global Rilpivirine Sales by Manufacturer, (K Pcs), 2017-2022 Table 14. Global Rilpivirine Sales Share by Manufacturer, 2017-2022 Table 15. Global Rilpivirine Price by Manufacturer (2017-2022) & (USD/Pcs) Table 16. Global Rilpivirine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Rilpivirine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rilpivirine as of 2021) Table 18. Top Players of Rilpivirine in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Rilpivirine Product Type Table 20. Date of International Manufacturers Enter into Rilpivirine Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Rilpivirine Players in United States Market, Ranking by Revenue (2021) Table 23. United States Rilpivirine Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Rilpivirine Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Rilpivirine Sales by Players, (K Pcs), 2020, 2021 & 2022 Table 26. United States Rilpivirine Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Rilpivirine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Rilpivirine Sales in Volume by Region (2017-2022) & (K Pcs) Table 29. Global Rilpivirine Sales in Volume Forecast by Region (2023-2028) & (K Pcs) Table 30. Global Rilpivirine Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Rilpivirine Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Rilpivirine Sales in Volume by Country (2017-2028) & (K Pcs) Table 33. North America Rilpivirine Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Rilpivirine Sales in Volume by Region (2017-2028) & (K Pcs) Table 35. Asia Pacific Rilpivirine Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Rilpivirine Sales in Volume by Country (2017-2028) & (K Pcs) Table 37. Europe Rilpivirine Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Rilpivirine Sales in Volume by Country (2017-2028) & (K Pcs) Table 39. Latin Americaa Rilpivirine Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Rilpivirine Sales in Volume by Country (2017-2028) & (K Pcs) Table 41. Middle East and Africa Rilpivirine Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Janssen Cilag International Corporation Information Table 43. Janssen Cilag International Description and Business Overview Table 44. Janssen Cilag International Rilpivirine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 45. Janssen Cilag International Rilpivirine Product Table 46. Janssen Cilag International Recent Development Table 47. Gilead Sciences Corporation Information Table 48. Gilead Sciences Description and Business Overview Table 49. Gilead Sciences Rilpivirine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 50. Gilead Sciences Product Table 51. Gilead Sciences Recent Development Table 52. ViiV Healthcare Corporation Information Table 53. ViiV Healthcare Description and Business Overview Table 54. ViiV Healthcare Rilpivirine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 55. ViiV Healthcare Product Table 56. ViiV Healthcare Recent Development Table 57. Strides Pharma Science Limited Corporation Information Table 58. Strides Pharma Science Limited Description and Business Overview Table 59. Strides Pharma Science Limited Rilpivirine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 60. Strides Pharma Science Limited Product Table 61. Strides Pharma Science Limited Recent Development Table 62. Pharmacare Limited Corporation Information Table 63. Pharmacare Limited Description and Business Overview Table 64. Pharmacare Limited Rilpivirine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 65. Pharmacare Limited Product Table 66. Pharmacare Limited Recent Development Table 67. Aspen Corporation Information Table 68. Aspen Description and Business Overview Table 69. Aspen Rilpivirine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 70. Aspen Product Table 71. Aspen Recent Development Table 72. Key Raw Materials Lists Table 73. Raw Materials Key Suppliers Lists Table 74. Rilpivirine Customers List Table 75. Rilpivirine Distributors List Table 76. Research Programs/Design for This Report Table 77. Key Data Information from Secondary Sources Table 78. Key Data Information from Primary Sources List of Figures Figure 1. Rilpivirine Product Picture Figure 2. Global Rilpivirine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Rilpivirine Market Size 2017-2028 (US$ Million) Figure 4. Global Rilpivirine Sales 2017-2028 (K Pcs) Figure 5. United States Rilpivirine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Rilpivirine Market Size 2017-2028 (US$ Million) Figure 7. United States Rilpivirine Sales 2017-2028 (K Pcs) Figure 8. United States Rilpivirine Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Rilpivirine Market Share in Global, in Volume (K Pcs) 2017-2028 Figure 10. Rilpivirine Report Years Considered Figure 11. Product Picture of Self-production API Figure 12. Product Picture of Outsourcing of API Figure 13. Global Rilpivirine Market Share by Type in 2022 & 2028 Figure 14. Global Rilpivirine Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Rilpivirine Sales Market Share in Value by Type (2017-2028) Figure 16. Global Rilpivirine Sales by Type (2017-2028) & (K Pcs) Figure 17. Global Rilpivirine Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Rilpivirine Price by Type (2017-2028) & (USD/Pcs) Figure 19. United States Rilpivirine Market Share by Type in 2022 & 2028 Figure 20. United States Rilpivirine Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Rilpivirine Sales Market Share in Value by Type (2017-2028) Figure 22. United States Rilpivirine Sales by Type (2017-2028) & (K Pcs) Figure 23. United States Rilpivirine Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Rilpivirine Price by Type (2017-2028) & (USD/Pcs) Figure 25. Product Picture of Hospital Figure 26. Product Picture of Clinic Figure 27. Product Picture of Drug Center Figure 28. Product Picture of Other Figure 29. Global Rilpivirine Market Share by Application in 2022 & 2028 Figure 30. Global Rilpivirine Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Rilpivirine Sales Market Share in Value by Application (2017-2028) Figure 32. Global Rilpivirine Sales by Application (2017-2028) & (K Pcs) Figure 33. Global Rilpivirine Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Rilpivirine Price by Application (2017-2028) & (USD/Pcs) Figure 35. United States Rilpivirine Market Share by Application in 2022 & 2028 Figure 36. United States Rilpivirine Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Rilpivirine Sales Market Share in Value by Application (2017-2028) Figure 38. United States Rilpivirine Sales by Application (2017-2028) & (K Pcs) Figure 39. United States Rilpivirine Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Rilpivirine Price by Application (2017-2028) & (USD/Pcs) Figure 41. North America Rilpivirine Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 42. North America Rilpivirine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Rilpivirine Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 46. Europe Rilpivirine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Rilpivirine Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 53. Asia-Pacific Rilpivirine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Rilpivirine Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 65. Latin America Rilpivirine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Rilpivirine Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 70. Middle East & Africa Rilpivirine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Rilpivirine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Rilpivirine Value Chain Figure 75. Rilpivirine Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed
Janssen Cilag International Gilead Sciences ViiV Healthcare Strides Pharma Science Limited Pharmacare Limited Aspen
Dolutegravir/Rilpivirine Combination Drug market is segmented by region (country), players, by Ty ... Read More